Cerus Revenue 2006-2019 | CERS

Cerus revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Cerus Annual Revenue
(Millions of US $)
2019 $94
2018 $76
2017 $51
2016 $39
2015 $34
2014 $36
2013 $40
2012 $37
2011 $33
2010 $23
2009 $18
2008 $17
2007 $11
2006 $30
2005 $13
Cerus Quarterly Revenue
(Millions of US $)
2019-12-31 $26
2019-09-30 $23
2019-06-30 $22
2019-03-31 $22
2018-12-31 $20
2018-09-30 $19
2018-06-30 $19
2018-03-31 $17
2017-12-31 $19
2017-09-30 $13
2017-06-30 $11
2017-03-31 $8
2016-12-31 $12
2016-09-30 $10
2016-06-30 $9
2016-03-31 $8
2015-12-31 $10
2015-09-30 $8
2015-06-30 $9
2015-03-31 $8
2014-12-31 $10
2014-09-30 $10
2014-06-30 $9
2014-03-31 $8
2013-12-31 $9
2013-09-30 $11
2013-06-30 $10
2013-03-31 $10
2012-12-31 $11
2012-09-30 $8
2012-06-30 $9
2012-03-31 $9
2011-12-31 $10
2011-09-30 $9
2011-06-30 $7
2011-03-31 $7
2010-12-31 $6
2010-09-30 $5
2010-06-30 $6
2010-03-31 $6
2009-12-31 $5
2009-09-30 $5
2009-06-30 $4
2009-03-31 $3
2008-12-31 $4
2008-09-30 $4
2008-06-30 $4
2008-03-31 $5
2007-12-31 $2
2007-09-30 $3
2007-06-30 $3
2007-03-31 $2
2006-12-31 $14
2006-09-30 $8
2006-06-30 $6
2006-03-31 $7
2005-12-31 $6
2005-09-30 $7
2005-06-30 $5
2005-03-31 $6
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.730B $0.075B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $135.026B 23.63
Medtronic (MDT) Ireland $112.721B 15.15
Stryker (SYK) United States $54.226B 17.51
Boston Scientific (BSX) United States $42.151B 18.99
Baxter (BAX) United States $39.901B 24.35
Coloplast (CLPBY) Denmark $31.763B 49.02
Lonza Group Ag (LZAGY) Switzerland $30.138B 0.00
Terumo (TRUMY) Japan $25.482B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $22.053B 0.00
ResMed (RMD) United States $20.578B 35.75
Zimmer Biomet Holdings (ZBH) United States $18.500B 11.39
Smith & Nephew SNATS (SNN) United Kingdom $14.780B 0.00
Sunny Optical Technology (SNPTF) China $14.456B 0.00
Bio-Rad Laboratories (BIO) United States $10.021B 46.83
Insulet (PODD) United States $10.006B 612.19
William Demant Holdings (WILYY) Denmark $7.898B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.329B 0.00
Hill-Rom Holdings (HRC) United States $6.975B 20.06
Perrigo (PRGO) Ireland $6.141B 11.19
GN STORE NORD (GNNDY) Denmark $6.057B 31.29
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Canopy Growth (CGC) Canada $4.744B 0.00
Haemonetics (HAE) United States $4.608B 28.36
ICU Medical (ICUI) United States $4.208B 27.48
Quidel (QDEL) United States $4.096B 35.96
Neogen (NEOG) United States $3.247B 55.00
GW Pharmaceuticals (GWPH) United Kingdom $2.628B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.374B 0.00
Agios Pharmaceuticals (AGIO) United States $2.360B 0.00
NuVasive (NUVA) United States $2.339B 18.09
Envista Holdings (NVST) United States $2.276B 0.00
National Vision Holdings (EYE) United States $1.322B 22.27
AtriCure (ATRC) United States $1.297B 0.00
Cardiovascular Systems (CSII) United States $1.246B 0.00
Aurora Cannabis (ACB) Canada $0.985B 0.00
TG Therapeutics (TGTX) United States $0.974B 0.00
Phibro Animal Health (PAHC) United States $0.965B 19.09
NanoString Technologies (NSTG) United States $0.820B 0.00
VAREX IMAGING (VREX) United States $0.794B 16.50
Aphria (APHA) $0.764B 0.00
OraSure Technologies (OSUR) United States $0.718B 89.08
Omeros (OMER) United States $0.702B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.695B 125.00
InMode (INMD) Israel $0.637B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.591B 35.15
PetIQ (PETQ) United States $0.570B 15.51
Quanterix (QTRX) United States $0.542B 0.00
Owens & Minor (OMI) United States $0.506B 13.85
LeMaitre Vascular (LMAT) United States $0.475B 26.73
Lantheus Holdings (LNTH) United States $0.461B 10.36
Surmodics (SRDX) United States $0.450B 51.80
Vapotherm (VAPO) United States $0.390B 0.00
Zynex (ZYXI) United States $0.358B 39.00
Meridian Bioscience (VIVO) United States $0.336B 13.52
Organigram Holdings (OGI) Canada $0.312B 0.00
Utah Medical Products (UTMD) United States $0.288B 20.64
Repro-Med Systems (KRMD) United States $0.271B 171.00
Cytosorbents (CTSO) United States $0.263B 0.00
MacroGenics (MGNX) United States $0.260B 0.00
Female Health (VERU) United States $0.202B 0.00
HEXO (HEXO) $0.195B 0.00
BioLife Solutions (BLFS) United States $0.188B 115.00
Exagen (XGN) United States $0.182B 0.00
InfuSystems Holdings (INFU) United States $0.172B 144.83
Viemed Healthcare (VMD) United States $0.172B 19.43
United Health Products (UEEC) United States $0.143B 0.00
Evolus (EOLS) United States $0.131B 0.00
Chembio Diagnostics (CEMI) United States $0.127B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Bovie Medical (APYX) United States $0.119B 0.00
Liberty Health Sciences (LHSIF) Canada $0.109B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.097B 0.00
Fonar (FONR) United States $0.091B 6.66
Chimerix (CMRX) United States $0.085B 0.00
Brainsway (BWAY) Israel $0.079B 0.00
MTech Acquisition (KERN) United States $0.070B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.064B 0.00
United-Guardian (UG) United States $0.063B 13.13
Nephros (NEPH) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
GUARDION HEALTH (GHSI) United States $0.032B 0.00
ImmuCell (ICCC) United States $0.031B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.028B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00